Literature DB >> 19195886

Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors.

Rainer Machauer1, Siem Veenstra, Jean-Michel Rondeau, Marina Tintelnot-Blomley, Claudia Betschart, Ulf Neumann, Paolo Paganetti.   

Abstract

The hydroxyethylene octapeptide inhibitor OM99-2 served as starting point to create the tripeptide inhibitor 1 and its analogues 2a and b. An X-ray co-crystal structure of 1 with BACE-1 allowed the design and syntheses of a series of macrocyclic analogues 3a-h covalently linking the P1 and P3 side-chains. These inhibitors show improved enzymatic potency over their open-chain analogue. Inhibitor 3h also shows activity in a cellular system.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19195886     DOI: 10.1016/j.bmcl.2009.01.036

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Development of an Efficient Enzyme Production and Structure-Based Discovery Platform for BACE1 Inhibitors.

Authors:  Yu-Chen Yen; Annalissa M Kammeyer; Katherine C Jensen; Jagannadharao Tirlangi; Arun K Ghosh; Andrew D Mesecar
Journal:  Biochemistry       Date:  2019-10-22       Impact factor: 3.162

Review 2.  The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors.

Authors:  Stefania Butini; Simone Brogi; Ettore Novellino; Giuseppe Campiani; Arun K Ghosh; Margherita Brindisi; Sandra Gemma
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

Review 3.  BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease.

Authors:  Arun K Ghosh; Heather L Osswald
Journal:  Chem Soc Rev       Date:  2014-10-07       Impact factor: 54.564

4.  Potent BACE-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies.

Authors:  Shalini John; Sundarapandian Thangapandian; Sugunadevi Sakkiah; Keun Woo Lee
Journal:  BMC Bioinformatics       Date:  2011-02-15       Impact factor: 3.169

5.  A Structure-Based Discovery Platform for BACE2 and the Development of Selective BACE Inhibitors.

Authors:  Yu-Chen Yen; Annalissa M Kammeyer; Jagannadharao Tirlangi; Arun K Ghosh; Andrew D Mesecar
Journal:  ACS Chem Neurosci       Date:  2021-02-05       Impact factor: 5.780

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.